A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Actym Therapeutics, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Elevation Oncology
Seagen Inc.
Sotio Biotech Inc.
Merck Sharp & Dohme LLC
ADC Therapeutics S.A.
Sumitomo Pharma America, Inc.
Pfizer
Fusion Pharmaceuticals Inc.
pharmaand GmbH
M.D. Anderson Cancer Center
Genmab
Xennials Therapeutics Australia Pty Ltd
MacroGenics
Tocagen Inc.
National Institutes of Health Clinical Center (CC)
CureOne
New Mexico Cancer Research Alliance
GlaxoSmithKline